PKCδ/midkine pathway drives hypoxia-induced proliferation and differentiation of human lung epithelial cells

American Journal of Physiology - Cell Physiology

Volumn 306, Issue 7, 2014, Pages

  Zhang, Hanying ^a   Okamoto, Miyako ^b   Panzhinskiy, Evgeniy ^c   Michael Zawada, W ^d   Das, Mita ^e  

^a UNIVERSITY OF WYOMING   (United States)

^b Kawahara Clinic   (Japan)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^e UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Differentiation; Hypoxia; Lung epithelial cells; Midkine; PKC ; Proliferation

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; MIDKINE; PROTEIN KINASE C DELTA; ROTTLERIN; SMALL INTERFERING RNA; VIMENTIN;

ARTICLE; CELL DIFFERENTIATION; CELL DIVISION; CELL LEVEL; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; EPITHELIUM CELL; HUMAN; HUMAN CELL; HYPOXIA; INTRACELLULAR TRANSPORT; LUNG ALVEOLUS EPITHELIUM; LUNG DISEASE; MESENCHYME CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

DIFFERENTIATION; HYPOXIA; LUNG EPITHELIAL CELLS; MIDKINE; PKCΔ; PROLIFERATION;

ACTINS; ACTIVE TRANSPORT, CELL NUCLEUS; ANTIBODIES, NEUTRALIZING; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL HYPOXIA; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; GOLGI APPARATUS; HUMANS; LUNG; NERVE GROWTH FACTORS; PHENOTYPE; PROTEIN KINASE C-DELTA; PROTEIN KINASE INHIBITORS; RECOMBINANT PROTEINS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION; VIMENTIN;

EID: 84900522831     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00351.2013     Document Type: Article

References (39)

1. Adamson IY, Young L, Bowden DH. Relationship of alveolar epithelial injury and repair to the induction of pulmonary fibrosis. Am J Pathol 130: 377-383, 1988.
2. Basu A, Pal D. Two faces of protein kinase Cδ: the contrasting roles of PKCδ in cell survival and cell death. Scientific World Journal 10: 2272-2284, 2010.
3. Chichger H, Grinnell KL, Casserly B, Chung CS, Braza J, Lomas-Neira J, Ayala A, Rounds S, Klinger JR, Harrington EO. Genetic disruption of protein kinase Cδ reduces endotoxin-induced lung injury. Am J Physiol Lung Cell Mol Physiol 303: L880-L888, 2012.
4. Clark AS, West KA, Blumberg PM, Dennis PA. Altered protein kinase C (PKC) isoforms in non-small cell lung cancer cells: PKCδ promotes cellular survival and chemotherapeutic resistance. Cancer Res 63: 780-786, 2003.
5. Das M, Bouchey DM, Moore M, Hopkins D, Nemenoff R, Stenmark KR. Hypoxia-induced proliferative response of pulmonary artery adventitial fibroblasts is dependent on G-protein mediated activation of MAP kinases. J Biol Chem 276: 15631-15640, 2001.
6. Das M, Burns N, Wilson SJ, Zawada WM, Stenmark KR. Hypoxia exposure induces the emergence of fibroblasts lacking replication repressor signals of PKCzeta in the pulmonary artery adventitia. Cardiovasc Res 78: 440-448, 2008.
7. Gomel R, Xiang C, Finniss S, Lee HK, Lu W, Okhrimenko H, Brodie C. The localization of protein kinase Cdelta in different subcellular sites affects its proapoptotic and antiapoptotic functions and the activation of distinct downstream signaling pathways. Mol Cancer Res 5: 627-639, 2007.
8. Griner EM, Kazanietz MG. Protein kinase C and other diacylglycerol effectors in cancer. Nat Rev Cancer 7: 281-294, 2007.
9. Grossoni VC, Falbo KB, Kazanittz MG, de Kier Joffe ED, Urtreger AJ. Protein kinase C delta enhances proliferation and survival of murine mammary cells. Mol Carcinog 46: 381-390, 2007.
10. Horiba M, Kadomatsu K, Nakamura E, Muramatsu H, Ikematsu S, Sakuma S, Hayashi K, Yuzawa Y, Matsuo S, Kuzuya M, Kaname T, Hirai M, Saito H, Muramatsu T. Neointima formation in a restenosis model is suppressed in midkine-deficient mice. J Clin Invest 105: 489-495, 2000.
11. Kadomatsu K. The midkine family in cancer, inflammation and neural development. Nagoya J Med Sci 67: 71-82, 2005.
12. Kang M, Walker JW. Protein kinase Cδ and aamediate positive inotrophy in adult ventricular myocytes. J Mol Cell Cardiol 38: 753-764, 2005.
13. Kasper M, Haroske G. Alterations in the alveolar epithelium after injury leading to pulmonary fibrosis. Histol Histopathol 11: 463-483, 1996.
14. Kikkawa U, Matsuzaki H, Yamamoto T. Protein kinase C (delta): activation mechanisms and functions. J Biochem (Tokyo) 132: 831-839, 2002.
15. Kosugi T, Yuzawa Y, Sato W, Kawai H, Matsuo S, Takei Y, Muramatsu T, Kadomatsu K. Growth factor midkine is involved in the pathogenesis of diabetic nephropathy. Am J Pathol 168: 9-19, 2006.
16. Kosugi T, Sato W. Midkine and the kidney: health and diseases. Nephrol Dial Transplant 27: 16-21, 2012.
17. Krick S, Eul BG, Hanze J, Saval R, Grimminger F, Seeger W. Role of hypoxia-inducible factor-1α in hypoxia-induced apoptosis of primary alveolar epithelial type II cells. Am J Respir Cell Mol Biol 32: 395-403, 2005.
18. Lee JW, Park JA, Kim SH, Seo JH, Lim KJ, Jeong JW, Jeong CH, Chun KH, Lee SK, Kwon YG, Kim KW. Protein Kinase Cδ regulates the stability of hypoxia-inducible factor-1α under hypoxia. Cancer Sci 98: 1476-1481, 2007.
19. Lounsbury KM, Stern M, Taatjes D, Jaken S, Mossman BT. Increased localization and substrate activation of protein kinase Cδ in lung epithelial cells following exposure to asbestos. Am J Pathol 160: 1991-2000, 2002.
20. Mellor H, Parker PJ. The extended protein kinase C superfamily. Biochem J 332: 281-292, 1998.
21. Muramatsu T. Midkine and pleiotrophin: two related proteins involved in development, survival, inflammation and tumorigenesis. J Biochem 132: 359-371, 2002.
22. Nakagawara A, Milbrandt J, Muramatsu T, Deuel TF, Zhao H, Cnaan A, Brodeur GM. Differential expression of pleiotrophin and midkine in advanced neuroblastomas. Cancer Res 55: 1792-1797, 1995.
23. Nordin SL, Jovic S, Kurut A, Andersson C, Gela A, Bjartell A, Morgelin M, Olin AI, Lund M, Egesten A. High expression of midkine in the airways of patients with cystic fibrosis. Am J Respir Cell Mol Biol 49: 935-942, 2013.
24. O'Brien T, Cranston D, Fuggle S, Bicknell R, Harris AL. The angiogenic factor midkine is expressed in bladder cancer, and overexpression correlates with a poor outcome in patients with invasive cancers. Cancer Res 56: 2515-2518, 1996.
25. Pal S, Claffey KP, Dvorak HF, Mukhopadhyay D. The von Hippel-Lindau gene product inhibits vascular permeability factor/vascular endothelial growth factor expression in renal cell carcinoma by blocking protein kinase C pathway. J Biol Chem 272: 27509-27512, 1997.
26. Reynolds PR, Mucenski ML, Le Cras TD, Nichols WC, Whitsett JA. Midkine is regulated by hypoxia and causes pulmonary vascular remodeling. J Biol Chem 279: 37124-37132, 2004.
27. Satelli A, Li S. Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol Life Sci 68: 3033-3046, 2011.
28. Short MD, Fox SM, Lam CF, Stenmark KR, Das M. PKCδ attenuates hypoxia-induced proliferation of fibroblasts by regulating MAP kinase phosphatase-1 expression. Mol Biol Cell 17: 1995-2008, 2006.
29. Short M, Nemenoff RA, Zawada WM, Stenmark KR, Das M. Hypoxia induces differentiation of pulmonary artery adventitial fibroblasts into myofibroblasts. Am J Physiol Cell Physiol 286: C416-C425, 2004.
30. Shukla A, Lounsbury KM, Barrett TF, Gell J, Rincon M, Butnor KJ, Taatjes DJ, Davis GS, Vacek P, Nakayama KI, Nakayama K, Steele C, Mossman. Regulation of interleukin-6 secretion by the two-pore-domain potassium channel Trek-1 in alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol 304: L276-L286, 2013.
31. Soltoff SP. Rottlerin: an inappropriate and ineffective inhibitor of PKCδ. Trends Pharmacol Sci 28: 453-458, 2007.
32. Steinberg SF. Distinctive activation mechanisms and functions for protein kinase Cδ. Biochem J 383: 449-59, 2004.
33. Stenmark KR, Davie NJ, Reeves JT, Frid MG. Hypoxia, leukocytes, and the pulmonary circulation. J Appl Physiol 98: 715-721, 2005.
34. Sulkowska M. Morphological studies of the lungs in chronic hypobaric hypoxia. Pol J Pathol 48: 225-234, 1997.
35. Tsutsui J, Kadomatsu K, Matsubara S, Nakagawara A, Hamanoue M, Takao S, Shimazu H, Ohi Y, Muramatsu T. A new family of heparinbinding growth/differentiation factors: increased midkine expression in Wilms' tumor and other human carcinomas. Cancer Res 53: 1281-1285, 1993.
36. Young TA, Wang H, Munk S, Hammoudi DS, Young DS, Mandelcorn MS, Whiteside CI. Vascular endothelial growth factor expression and secretion by retinal pigment epithelial cells in high glucose and hypoxia is protein kinase C-dependent. Exp Eye Res 80: 651-662, 2005.
37. Weckbach LT, Groesser L, Borgolte J, Pagel JI, Pogoda F, Schymeinsky J, Muller-Hocker J, Shakibaei M, Muramatsu T, Deindl E, Walzog B. Midkine acts as proangiogenic cytokine in hypoxia-induced angiogenesis. Am J Physiol Heart Circ Physiol 303: H429-H438, 2012.
38. Zhao G, Nie Y, Lv M, He L, Wang T, Hou Y. ERβ-mediated estradiol enhances epithelial mesenchymal transition of lung adenocarcinoma through increasing transcription of midkine. Mol Endocrinol 26: 1304-1315, 2012.
39. Zhou G, Dada LA, Wu M, Kelly A, Trejo H, Zhou Q, Varga J, Sznajder JI. Hypoxia-induced alveolar epithelial-mesenchymal transition requires mitochondrial ROS and hypoxia-inducible factor 1. Am J Physiol Lung Cell Mol Physiol 297: L1120-L1130, 2009.